Filing metadata

Accession number
0001209191-22-059261
Form type
Form 3
Filer
Spyre Therapeutics, Inc.
CIK
CIK 1636282
Filed
Dec 01, 2022
Reporting period
Nov 29, 2022
Description
Initial ownership

Explore SEC Filings Hub